← Leaderboards
Orly Vardeny
Brigham And Women'S Hospital
$9,799,841
Attributed
$19,867,616
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.8M · FY2016–25$10M$7.5M$5M$2.5M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,867,616 · 2
By mechanism
U01$19,063,815 · 1
R01$803,801 · 1
Top collaborators
- Scott David Solomon4 shared
- Kristina Anne Crothers1 shared
- Ken M. Kunisaki1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Sara K. Tedeschi$1,893,574
- Gezzer Ortega$690,976
- Susan Cheng$21,020,819
- Sophia Koo$15,534,982
- Ingrid T. Katz$3,944,890
Others in their field
Top investigators on “Electronic Health Record”
- Larry Arthur$206,000,000
- Lee Marshall Nadler · Dana-Farber Cancer Inst$123,638,056
- Asimah Rafi · Technical Resources Inc$95,881,052
- Daniel Ernest Ford · Johns Hopkins University$75,786,253
- Rosalind J Wright · Icahn School Of Medicine At Mount Sinai$65,323,579
- Robert P Kimberly · University Of Alabama At Birmingham$64,527,475
Research focus
Electronic Health RecordRandomizedVaccinationHospitalizationCause Of DeathPrimary OutcomeMortalitySecondary OutcomeActive ControlAcute Myocardial InfarctionCenters For Disease Control And Prevention (U.S.)CollegeAmericanAmerican Heart AssociationAdultCardiovascular Risk FactorChestAchievementAcute Coronary SyndromeCardiacCardiologyCardiopulmonaryCardiovascular DiseasesAntibody Response
Grant awards (5)
Optimizing Medications and Lung Health in People with HIV through Pharmacist-led Proactive E-Consults (OPTIMIZE Lung-HIV)$803,801
R01 · FY2025 · HL
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated heart failure (INVESTED)$4,985,286
U01 · FY2019 · HL
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated heart failure (INVESTED)$6,828,478
U01 · FY2018 · HL
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated heart failure (INVESTED)$5,915,597
U01 · FY2017 · HL
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated heart failure (INVESTED)$1,334,454
U01 · FY2016 · HL